Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II study.
Nistico C, Bria E, Agostara B, Barni S, Colella E, Frontini L, D'Ottavio AM, Cuppone F, Valenza R, Sperduti I, Izzo F, Terzoli E. Nistico C, et al. Among authors: d ottavio am. Anticancer Drugs. 2006 Mar;17(3):345-51. doi: 10.1097/00001813-200603000-00014. Anticancer Drugs. 2006. PMID: 16520664 Clinical Trial.
Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal women.
Milella M, Nisticò C, Ferraresi V, Vaccaro A, Fabi A, D'Ottavio AM, Botti C, Giannarelli D, Lopez M, Cortesi E, Foggi CM, Antimi M, Terzoli E, Cognetti F, Papaldo P. Milella M, et al. Among authors: d ottavio am. Breast Cancer Res Treat. 1999 Jun;55(3):259-66. doi: 10.1023/a:1006276120841. Breast Cancer Res Treat. 1999. PMID: 10517170 Clinical Trial.
Weekly epirubicin plus lonidamine in advanced breast carcinoma.
Nisticò C, Garufi C, Milella M, D'Ottavio AM, Vaccaro A, Fabi A, Terzoli E. Nisticò C, et al. Among authors: d ottavio am. Breast Cancer Res Treat. 1999 Aug;56(3):233-7. doi: 10.1023/a:1006213815195. Breast Cancer Res Treat. 1999. PMID: 10573114 Clinical Trial.
Weekly schedule of vinorelbine in pretreated breast cancer patients.
Nisticò C, Garufi C, Milella M, Vaccaro A, D'Ottavio AM, Fabi A, Pace A, Bove L, Tropea F, Marsella A, Izzo F, D'Attino RM, Ferraresi V, De Marco S, Terzoli E. Nisticò C, et al. Among authors: d ottavio am. Breast Cancer Res Treat. 2000 Feb;59(3):223-9. doi: 10.1023/a:1006390700480. Breast Cancer Res Treat. 2000. PMID: 10832592 Clinical Trial.
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer.
Fabi A, Alesini D, Valle E, Moscetti L, Caputo R, Caruso M, Carbognin L, Ciccarese M, La Verde N, Arpino G, Cannita K, Paris I, Santini D, Montemurro F, Russillo M, Ferretti G, Filippelli G, Rossello R, Fabbri A, Zambelli A, Leonardi V, D'Ottavio AM, Nisticò C, Stani S, Giampaglia M, Scandurra G, Catania G, Malaguti P, Giannarelli D, Cognetti F. Fabi A, et al. Among authors: d ottavio am. Breast. 2018 Oct;41:137-143. doi: 10.1016/j.breast.2018.07.004. Epub 2018 Jul 12. Breast. 2018. PMID: 30092500
12 results